BioSpace News Archive

Policy

Inventor Of “LessDrops,” Surgical Eyedrop, Wins Return Of Patent From Harrow Health

Novel Drug Solutions, LLC and Eye Care Northwest, PA, announce the return of their unrestricted patent rights to several awarded and pending USA and international patents previously controlled by Harrow Health, Inc..

December 10, 2019
·
3 min read
Biotech Bay

Personalis, Inc. to Present at ESMO Immuno-Oncology Congress 2019

ImmunoID NeXT™ is the first platform to enable comprehensive analysis of both a tumor and its immune microenvironment from a single sample.

December 10, 2019
·
2 min read
Genetown

Constellation Pharmaceuticals Announces Pricing of Public Offering of Common Stock

The offering is expected to close on December 13, 2019, subject to customary closing conditions.

December 10, 2019
·
5 min read
Drug Development

Ascentage Pharma Releases Updated Data of its Novel BCR-ABL Inhibitor, HQP1351, in an Oral Presentation Nominated for “Best of ASH”

At the 61st American Society of Hematology Annual Meeting

December 10, 2019
·
5 min read
Deals

Rocket Pharmaceuticals Prices Public Offering of Common Stock - Dec. 11, 2019

Rocket Pharmaceuticals, Inc. announces the pricing of an underwritten public offering of 3,820,000 shares of its common stock at a public offering price of $22.25 per share.

December 10, 2019
·
5 min read
BioCapital

Diffusion Pharmaceuticals Presents Data Suggesting Optimized TSC Dosing Regimen Increases Survival in Newly Diagnosed Inoperable Glioblastoma Patients

Presentation Made by Chief Scientific Officer John Gainer at the Inaugural Glioblastoma Drug Development

December 10, 2019
·
7 min read
Deals

Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Dec. 10, 2019

Endologix, Inc., a developer and marketer of innovative treatments for aortic disorders, announced the grant of an inducement equity award to a newly hired employee.

December 10, 2019
·
1 min read
Business

François Nader, M.D., Joins Moderna’s Board of Directors

Former CEO of NPS Pharmaceuticals brings broad expertise to support Moderna’s progress towards late-stage development and commercialization

December 10, 2019
·
5 min read
Business

National Experts in Autoimmunity Tapped to Serve on Exagen’s Scientific Advisory Board

Exagen Inc. announced that it has formed a Scientific Advisory Board consisting of national experts in the clinical management of rheumatic autoimmune diseases including rheumatoid arthritis and lupus.

December 10, 2019
·
10 min read
Policy

AgeX Therapeutics and Lineage Cell Therapeutics Announce Issuance of U.S. Patent for Method of Generating Induced Pluripotent Stem Cells

AgeX Therapeutics, Inc. and Lineage Cell Therapeutics, Inc., announced that the United States Patent and Trademark Office has issued U.S. Patent No. 10,501,723, entitled “Methods of Reprogramming Animal Somatic Cells” covering what is commonly designated “induced Pluripotent Stem cells.

December 10, 2019
·
7 min read